The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Keynote-200 phase 1b: A novel combination study of intravenously delivered coxsackievirus A21 and pembrolizumab in advanced cancer patients.
 
Hardev S. Pandha
Speakers' Bureau - Viralytics
Research Funding - Viralytics
Patents, Royalties, Other Intellectual Property - Viralytics
Travel, Accommodations, Expenses - Viralytics
 
Christy Ralph
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Viralytics (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; GlaxoSmithKline; Janssen; Roche
 
Kevin Harrington
Honoraria - Amgen
Speakers' Bureau - Amgen
Research Funding - Viralytics (Inst)
Travel, Accommodations, Expenses - Viralytics
 
Brendan D. Curti
Honoraria - Prometheus
Speakers' Bureau - Bristol-Myers Squibb; Prometheus
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Prometheus (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Agonox; Prometheus
 
Rachel E. Sanborn
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen; ARIAD; Genentech/Roche; Peregrine Pharmaceuticals; Seagen
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck
Travel, Accommodations, Expenses - Five Prime Therapeutics
 
Wallace L. Akerley
No Relationships to Disclose
 
Sumati Gupta
Stock and Other Ownership Interests - Salarius Pharmaceuticals (I)
Consulting or Advisory Role - Keryx (I)
Research Funding - Hydrocephalus Clinical Research Network (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Keryx (I)
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; AVEO; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Novartis
Research Funding - Biomarin
 
Jonathan E. Rosenberg
Stock and Other Ownership Interests - Illumina; Merck
Honoraria - AstraZeneca; Bristol-Myers Squibb; UpToDate
Consulting or Advisory Role - Agensys; AstraZeneca/MedImmune; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Lilly; Merck; Oncogenex; Roche/Genentech; Sanofi; Seagen
Research Funding - Agensys (Inst); Genentech (Inst); Genentech/Roche (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Viralytics (Inst)
Patents, Royalties, Other Intellectual Property - ERCC2 predicting cisplatin sensitivity
Travel, Accommodations, Expenses - Genentech/Roche
 
David Ross Kaufman
Employment - Merck
 
Emmett V. Schmidt
Employment - Merck
 
Mark Grose
Employment - Viralytics
 
Darren Shafren
Employment - Viralytics
Leadership - Viralytics
Stock and Other Ownership Interests - Viralytics
Consulting or Advisory Role - Viralytics
Research Funding - Viralytics
Patents, Royalties, Other Intellectual Property - Viralytics
Travel, Accommodations, Expenses - Viralytics
Other Relationship - Viralytics